Form 144 - Report of proposed sale of securities:
SEC Accession No. 0002007317-25-000698
Filing Date
2025-07-10
Accepted
2025-07-10 15:55:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4123
  Complete submission text file 0002007317-25-000698.txt   5709
Mailing Address C/O VERRICA PHARMACEUTICALS INC. 10 NORTH HIGH STREET, SUITE 200 WEST CHESTER PA 19380
Business Address
Burnett Patrick (Reporting) CIK: 0001741987 (see all company filings)

Type: 144

Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Subject) CIK: 0001787306 (see all company filings)

EIN.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39186 | Film No.: 251116253
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)